These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38557731)
21. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes. Aragon-Sanchez S; Oliver-Perez MR; Madariaga A; Tabuenca MJ; Martinez M; Galindo A; Arroyo ML; Gallego M; Blanco M; Ciruelos-Gil EM Breast J; 2022; 2022():1507881. PubMed ID: 36051467 [TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-assisted axillary staging: an alternative approach after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers. Yang J; He T; Wu Y; Fu Z; Lv Q; Lu S; Wang X; Li H; Wang J; Chen J Breast Cancer Res Treat; 2022 Apr; 192(3):573-582. PubMed ID: 35129717 [TBL] [Abstract][Full Text] [Related]
23. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
24. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336 [TBL] [Abstract][Full Text] [Related]
25. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528 [TBL] [Abstract][Full Text] [Related]
26. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study. Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C Breast J; 2022; 2022():6111907. PubMed ID: 35855102 [TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer. Wu X; Tang L; Huang W; Huang S; Peng W; Hu D Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000 [TBL] [Abstract][Full Text] [Related]
29. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793 [TBL] [Abstract][Full Text] [Related]
30. Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer. Kuemmel S; Heil J; Bruzas S; Breit E; Schindowski D; Harrach H; Chiari O; Hellerhoff K; Bensmann E; Hanf V; Graßhoff ST; Deuschle P; Belke K; Polata S; Paepke S; Warm M; Meiler J; Schindlbeck C; Ruhwedel W; Beckmann U; Groh U; Dall P; Blohmer JU; Traut A; Reinisch M JAMA Surg; 2023 Aug; 158(8):807-815. PubMed ID: 37285140 [TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457 [TBL] [Abstract][Full Text] [Related]
32. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371 [TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234 [TBL] [Abstract][Full Text] [Related]
34. Use of ultrasound and MRI to stage the axilla for breast cancer before and after neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy. Brabender D; Ballard A; Kim S; Hovanessian-Larsen L; Sener SF Breast Cancer Res Treat; 2024 Aug; 206(3):595-602. PubMed ID: 38700572 [TBL] [Abstract][Full Text] [Related]
35. Targeted axillary dissection using Radioguided Occult Lesion Localization technique in the clinically negative marked lymph node after neoadjuvant treatment in breast cancer patients. Del Castillo A; Gomez-Modet S; Mata JM; Tejedor L Eur J Surg Oncol; 2023 Jul; 49(7):1184-1188. PubMed ID: 36958951 [TBL] [Abstract][Full Text] [Related]
36. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment. Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804 [TBL] [Abstract][Full Text] [Related]
37. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer. Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955 [TBL] [Abstract][Full Text] [Related]
38. Clinical Impact of Fine Needle Aspiration Cytology on Sentinel Node Biopsy after Preoperative Chemotherapy for Core Needle Biopsy-Proven Metastatic Lymph Nodes. Nakamura R; Hayama S; Yoshimura S; Itami M; Araki A; Odaka A; Yamamoto N Acta Cytol; 2023; 67(4):378-387. PubMed ID: 36796341 [TBL] [Abstract][Full Text] [Related]
39. Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study. Munck F; Jensen MB; Vejborg I; Gerlach MK; Maraldo MV; Kroman NT; Tvedskov THF Ann Surg Oncol; 2024 Aug; 31(8):5157-5167. PubMed ID: 38704502 [TBL] [Abstract][Full Text] [Related]
40. [Normalization in axillary lymph node management after neoadjuvant therapy for breast cancer]. Wu D; Liu SY; Amina M; Fan ZM Zhonghua Wai Ke Za Zhi; 2019 Feb; 57(2):97-101. PubMed ID: 30704211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]